Neurogenerative Diseases Flashcards
Levodopa MOA
increases dopament synthesis
Selegiline
Inhibits dopamine breakdown
- inhibits monoamine oxidase type B (MAO-B)
Indicated; single drug for early/ mild PD, adjunct to levodopa-carbidopa for advanced disease (reduces need to >> levodopa dosage).
++ can improve motor function in patients who experience wearing off and on-off difficulties with Levodopa.
Carbidopa and entacapone
increases the amount of levodopa that enters the brain
What’s the relationship of Levodopa and protein?
Levodopa is absorbed from the proximal duodenum.
Amino acids compete with levodopa for transport into circulation.
Therefore high protein meals can decrease effectiveness of levodopa.
NB> Vit B6 should not be adminstered wthi levodopa.
Donzepezil
Alzheimer’s Disease
Increases availability of acetylcholine in the brain.
Central Acetylcholinesterase Inhibitor
Why is it important to combine carbidopa with levodopa?
To block the peripheral formation of dopamine. Dopamine acts on B-adrenoceptors and can cause arrhythmias.
Adverse effects of levodopa:
80% px - nausea and vomiting
25% px - orthostatic hypotension
10% px - cardiac dysrhythmia
What’s the problem with long-term adminstration of Levodopa?
Dyskinesias; oral and facial musculature. Px appear if they are chewing on large pieces of food while protruding their lips.
Also; writhing and flinging movements of arms and legs. Rarely psychotic effects.
Bromocriptine (ergot alkaloid)
D2 receptor agonist and D1 receptor antagonist
Combined with levodopa in patients with advanced PD and who experience wearing off and on-off motor fluctuations.
Ropinirole (not ergot alkaloids)
- selective D2 receptor agonists
Can delay the need for levodopa when used in early stages of PD.
Also indicated for restless leg syndrome.
Drugs for Huntington Disease
Diazepam
Haloperidol
Drugs for MS
Baclofen
Interferon beta-1b
Prednisone
Three drugs used to treat Alzheimer’s disease
Donepezil
Rivastigmine
Galantamine
Amantadine
Increases dopamine release in the basal ganglia; used for Parkinson’s disease
Memantine
New drug to treat AD
NMDA receptor antagonist